Patient and caregiver quality of life in Huntington's disease
- PMID: 18175350
- PMCID: PMC3789516
- DOI: 10.1002/mds.21920
Patient and caregiver quality of life in Huntington's disease
Abstract
Little is known about subjective perceptions of quality of life (QOL) in Huntington's disease (HD). The current study determined correlates of patient and caregiver QOL and assessed change over time. Participants were 22 patient-caregiver dyads, who rated QOL at baseline and 6 months later. Overall, patients' functional and cognitive impairment were significantly correlated with patient and caregiver QOL. Neuropsychiatric symptoms had differential impact on patient and caregiver QOL. Furthermore, when patients recalled their QOL about a previous time, their recall may have been negatively biased. Clinical implications of results are discussed. Future work is needed because subjective QOL is an important outcome measure in therapeutic trials.
2008 Movement Disorder Society
References
-
- Penney JBJ, Young AB, Shoulson I, et al. Huntington’s disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals. Mov Disord. 1990;5:93–99. - PubMed
-
- Bamford KA, Caine ED, Kido DK, et al. A prospective evaluation of cognitive decline in early Huntington’s disease: Functional and radiographic correlates. Neurology. 1995;45:1867–1873. - PubMed
-
- Thompson JC, Snowden JS, Craufurd D, et al. Behavior in Huntington’s disease: Dissociating cognition-based and mood-based changes. J Neuropsychiatry Clin Neurosci. 2002;14:37–43. - PubMed
-
- Helder DI, Kaptein AA, van Kempen GMJ, et al. Impact of Huntington’s disease on quality of life. Mov Disord. 2001;16:325–330. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases